Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 21 of 21 entries
Sorted by: Best Match Show Resources per page
Hormonal response to dobutamine cardiac stress testing in a conscious canine model of early left ventricular dysfunction induced by chronic rate overload.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology

Mc Entee K, Clercx C, Flandre T, Jonville E, Pynnaert C, Van Beneden R, Ketelslegers J, Michaux C, Balligand M, Miserque N, Henroteaux M.
PMID: 19081329
J Vet Cardiol. 2000 Dec;2(2):7-14. doi: 10.1016/S1760-2734(06)70006-6.

The aims of this study were to investigate (1) hormonal activation before and during dobutamine cardiac stress testing (DST) in a canine model of early left ventricular dysfunction (ELVD) induced by rapid right ventricular pacing (RRVP) and (2) the...

Cite
Mc Entee K, Clercx C, Flandre T, et al. Hormonal response to dobutamine cardiac stress testing in a conscious canine model of early left ventricular dysfunction induced by chronic rate overload. J Vet Cardiol. 2000;2(2):7-14doi: 10.1016/S1760-2734(06)70006-6.
Mc Entee, K., Clercx, C., Flandre, T., Jonville, E., Pynnaert, C., Van Beneden, R., Ketelslegers, J., Michaux, C., Balligand, M., Miserque, N., & Henroteaux, M. (2000). Hormonal response to dobutamine cardiac stress testing in a conscious canine model of early left ventricular dysfunction induced by chronic rate overload. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2(2), 7-14. https://doi.org/10.1016/S1760-2734(06)70006-6
Mc Entee, K, et al. "Hormonal response to dobutamine cardiac stress testing in a conscious canine model of early left ventricular dysfunction induced by chronic rate overload." Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology vol. 2,2 (2000): 7-14. doi: https://doi.org/10.1016/S1760-2734(06)70006-6
Mc Entee K, Clercx C, Flandre T, Jonville E, Pynnaert C, Van Beneden R, Ketelslegers J, Michaux C, Balligand M, Miserque N, Henroteaux M. Hormonal response to dobutamine cardiac stress testing in a conscious canine model of early left ventricular dysfunction induced by chronic rate overload. J Vet Cardiol. 2000 Dec;2(2):7-14. doi: 10.1016/S1760-2734(06)70006-6. PMID: 19081329.
Copy Download .nbib Format: NLM
Can stress make you relax?.

Cardiovascular research

Balligand JL, Farah C.
PMID: 29438492
Cardiovasc Res. 2018 Apr 01;114(5):643-644. doi: 10.1093/cvr/cvy027.

No abstract available.

Cite
Balligand JL, Farah C. Can stress make you relax?. Cardiovasc Res. 2018;114(5):643-644doi: 10.1093/cvr/cvy027.
Balligand, J. L., & Farah, C. (2018). Can stress make you relax?. Cardiovascular research, 114(5), 643-644. https://doi.org/10.1093/cvr/cvy027
Balligand, Jean-Luc, and Farah, Charlotte. "Can stress make you relax?." Cardiovascular research vol. 114,5 (2018): 643-644. doi: https://doi.org/10.1093/cvr/cvy027
Balligand JL, Farah C. Can stress make you relax?. Cardiovasc Res. 2018 Apr 01;114(5):643-644. doi: 10.1093/cvr/cvy027. PMID: 29438492.
Copy Download .nbib Format: NLM
You 'heart' what you eat!.

Cardiovascular research

Balligand JL, Bertrand L.
PMID: 33772583
Cardiovasc Res. 2021 Sep 28;117(11):2294-2296. doi: 10.1093/cvr/cvab118.

No abstract available.

Cite
Balligand JL, Bertrand L. You 'heart' what you eat!. Cardiovasc Res. 2021;117(11):2294-2296doi: 10.1093/cvr/cvab118.
Balligand, J. L., & Bertrand, L. (2021). You 'heart' what you eat!. Cardiovascular research, 117(11), 2294-2296. https://doi.org/10.1093/cvr/cvab118
Balligand, Jean-Luc, and Bertrand, Luc. "You 'heart' what you eat!." Cardiovascular research vol. 117,11 (2021): 2294-2296. doi: https://doi.org/10.1093/cvr/cvab118
Balligand JL, Bertrand L. You 'heart' what you eat!. Cardiovasc Res. 2021 Sep 28;117(11):2294-2296. doi: 10.1093/cvr/cvab118. PMID: 33772583.
Copy Download .nbib Format: NLM
You 'heart' what you eat!.

Cardiovascular research

Balligand JL, Bertrand L.
PMID: 33772583
Cardiovasc Res. 2021 Sep 28;117(11):2294-2296. doi: 10.1093/cvr/cvab118.

No abstract available.

Cite
Balligand JL, Bertrand L. You 'heart' what you eat!. Cardiovasc Res. 2021;117(11):2294-2296doi: 10.1093/cvr/cvab118.
Balligand, J. L., & Bertrand, L. (2021). You 'heart' what you eat!. Cardiovascular research, 117(11), 2294-2296. https://doi.org/10.1093/cvr/cvab118
Balligand, Jean-Luc, and Bertrand, Luc. "You 'heart' what you eat!." Cardiovascular research vol. 117,11 (2021): 2294-2296. doi: https://doi.org/10.1093/cvr/cvab118
Balligand JL, Bertrand L. You 'heart' what you eat!. Cardiovasc Res. 2021 Sep 28;117(11):2294-2296. doi: 10.1093/cvr/cvab118. PMID: 33772583.
Copy Download .nbib Format: NLM
Cancer and Peripartum Cardiomyopathy: A Diabolic Couple.

JACC. CardioOncology

Balligand JL.
PMID: 34396184
JACC CardioOncol. 2019 Dec 17;1(2):206-207. doi: 10.1016/j.jaccao.2019.10.005. eCollection 2019 Dec.

No abstract available.

Cite
Balligand JL. Cancer and Peripartum Cardiomyopathy: A Diabolic Couple. JACC CardioOncol. 2019;1(2):206-207doi: 10.1016/j.jaccao.2019.10.005.
Balligand, J. L. (2019). Cancer and Peripartum Cardiomyopathy: A Diabolic Couple. JACC. CardioOncology, 1(2), 206-207. https://doi.org/10.1016/j.jaccao.2019.10.005
Balligand, Jean-Luc. "Cancer and Peripartum Cardiomyopathy: A Diabolic Couple." JACC. CardioOncology vol. 1,2 (2019): 206-207. doi: https://doi.org/10.1016/j.jaccao.2019.10.005
Balligand JL. Cancer and Peripartum Cardiomyopathy: A Diabolic Couple. JACC CardioOncol. 2019 Dec 17;1(2):206-207. doi: 10.1016/j.jaccao.2019.10.005. eCollection 2019 Dec. PMID: 34396184; PMCID: PMC8352180.
Copy Download .nbib Format: NLM
Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.

JCI insight

De Pauw A, Andre E, Sekkali B, Bouzin C, Esfahani H, Barbier N, Loriot A, De Smet C, Vanhoutte L, Moniotte S, Gerber B, di Mauro V, Catalucci D, Feron O, Hilfiker-Kleiner D, Balligand JL.
PMID: 28614798
JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.91810. eCollection 2017 Jun 15.

Adult cardiac progenitor cells (CPCs) display a low capacity to differentiate into cardiomyocytes in injured hearts, strongly limiting the regenerative capacity of the mammalian myocardium. To identify new mechanisms regulating CPC differentiation, we used primary and clonally expanded Sca-1+...

Cite
De Pauw A, Andre E, Sekkali B, et al. Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. JCI Insight. 2017;2(12)doi: 10.1172/jci.insight.91810.
De Pauw, A., Andre, E., Sekkali, B., Bouzin, C., Esfahani, H., Barbier, N., Loriot, A., De Smet, C., Vanhoutte, L., Moniotte, S., Gerber, B., di Mauro, V., Catalucci, D., Feron, O., Hilfiker-Kleiner, D., & Balligand, J. L. (2017). Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. JCI insight, 2(12), . https://doi.org/10.1172/jci.insight.91810
De Pauw, Aurelia, et al. "Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction." JCI insight vol. 2,12 (2017). doi: https://doi.org/10.1172/jci.insight.91810
De Pauw A, Andre E, Sekkali B, Bouzin C, Esfahani H, Barbier N, Loriot A, De Smet C, Vanhoutte L, Moniotte S, Gerber B, di Mauro V, Catalucci D, Feron O, Hilfiker-Kleiner D, Balligand JL. Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.91810. eCollection 2017 Jun 15. PMID: 28614798; PMCID: PMC5470891.
Copy Download .nbib Format: NLM
Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation.

Journal of leukocyte biology

Piperoglou C, Larid G, Vallentin B, Balligand L, Crinier A, Banzet N, Farnarier C, Gomez-Massa E, Adalia AC, Michel G, Galambrun C, Barlogis V, Vivier E, Vély F.
PMID: 33847423
J Leukoc Biol. 2022 Jan;111(1):161-172. doi: 10.1002/JLB.5A1019-522RR. Epub 2021 Apr 13.

Lymphocytes are essential for microbial immunity, tumor surveillance, and tissue homeostasis. However, the in vivo development and function of helper-like innate lymphoid cells (ILCs) in humans remain much less well understood than those of T, B, and NK cells....

Cite
Piperoglou C, Larid G, Vallentin B, et al. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. J Leukoc Biol. 2021;111(1):161-172doi: 10.1002/JLB.5A1019-522RR.
Piperoglou, C., Larid, G., Vallentin, B., Balligand, L., Crinier, A., Banzet, N., Farnarier, C., Gomez-Massa, E., Adalia, A. C., Michel, G., Galambrun, C., Barlogis, V., Vivier, E., & Vély, F. (2022). Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Journal of leukocyte biology, 111(1), 161-172. https://doi.org/10.1002/JLB.5A1019-522RR
Piperoglou, Christelle, et al. "Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation." Journal of leukocyte biology vol. 111,1 (2022): 161-172. doi: https://doi.org/10.1002/JLB.5A1019-522RR
Piperoglou C, Larid G, Vallentin B, Balligand L, Crinier A, Banzet N, Farnarier C, Gomez-Massa E, Adalia AC, Michel G, Galambrun C, Barlogis V, Vivier E, Vély F. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. J Leukoc Biol. 2022 Jan;111(1):161-172. doi: 10.1002/JLB.5A1019-522RR. Epub 2021 Apr 13. PMID: 33847423.
Copy Download .nbib Format: NLM
AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism.

Basic research in cardiology

Dufeys C, Daskalopoulos EP, Castanares-Zapatero D, Conway SJ, Ginion A, Bouzin C, Ambroise J, Bearzatto B, Gala JL, Heymans S, Papageorgiou AP, Vinckier S, Cumps J, Balligand JL, Vanhaverbeke M, Sinnaeve P, Janssens S, Bertrand L, Beauloye C, Horman S.
PMID: 33564961
Basic Res Cardiol. 2021 Feb 09;116(1):10. doi: 10.1007/s00395-021-00846-y.

We have previously demonstrated that systemic AMP-activated protein kinase α1 (AMPKα1) invalidation enhanced adverse LV remodelling by increasing fibroblast proliferation, while myodifferentiation and scar maturation were impaired. We thus hypothesised that fibroblastic AMPKα1 was a key signalling element in...

Cite
Dufeys C, Daskalopoulos EP, Castanares-Zapatero D, et al. AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism. Basic Res Cardiol. 2021;116(1):10doi: 10.1007/s00395-021-00846-y.
Dufeys, C., Daskalopoulos, E. P., Castanares-Zapatero, D., Conway, S. J., Ginion, A., Bouzin, C., Ambroise, J., Bearzatto, B., Gala, J. L., Heymans, S., Papageorgiou, A. P., Vinckier, S., Cumps, J., Balligand, J. L., Vanhaverbeke, M., Sinnaeve, P., Janssens, S., Bertrand, L., Beauloye, C., & Horman, S. (2021). AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism. Basic research in cardiology, 116(1), 10. https://doi.org/10.1007/s00395-021-00846-y
Dufeys, Cécile, et al. "AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism." Basic research in cardiology vol. 116,1 (2021): 10. doi: https://doi.org/10.1007/s00395-021-00846-y
Dufeys C, Daskalopoulos EP, Castanares-Zapatero D, Conway SJ, Ginion A, Bouzin C, Ambroise J, Bearzatto B, Gala JL, Heymans S, Papageorgiou AP, Vinckier S, Cumps J, Balligand JL, Vanhaverbeke M, Sinnaeve P, Janssens S, Bertrand L, Beauloye C, Horman S. AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism. Basic Res Cardiol. 2021 Feb 09;116(1):10. doi: 10.1007/s00395-021-00846-y. PMID: 33564961; PMCID: PMC7873123.
Copy Download .nbib Format: NLM
Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response.

Clinical and translational science

Stillemans G, Paquot A, Muccioli GG, Hoste E, Panin N, Åsberg A, Balligand JL, Haufroid V, Elens L.
PMID: 34761521
Clin Transl Sci. 2021 Nov 10; doi: 10.1111/cts.13185. Epub 2021 Nov 10.

The purpose of this study was to investigate the potential clinical relevance of estimating the apparent clearance (CL/F) of atorvastatin through population pharmacokinetic (PopPK) modeling with samples collected in a real-life setting in a cohort of ambulatory patients at...

Cite
Stillemans G, Paquot A, Muccioli GG, et al. Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response. Clin Transl Sci. 2021;doi: 10.1111/cts.13185.
Stillemans, G., Paquot, A., Muccioli, G. G., Hoste, E., Panin, N., Åsberg, A., Balligand, J. L., Haufroid, V., & Elens, L. (2021). Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response. Clinical and translational science, . https://doi.org/10.1111/cts.13185
Stillemans, Gabriel, et al. "Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response." Clinical and translational science vol. (2021). doi: https://doi.org/10.1111/cts.13185
Stillemans G, Paquot A, Muccioli GG, Hoste E, Panin N, Åsberg A, Balligand JL, Haufroid V, Elens L. Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response. Clin Transl Sci. 2021 Nov 10; doi: 10.1111/cts.13185. Epub 2021 Nov 10. PMID: 34761521.
Copy Download .nbib Format: NLM
Showing 13 to 21 of 21 entries